Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Paul Dayton
AddedMar 31, 2024
UpdatedMay 31, 2026
Paul Dayton

Paul Dayton

Co-Founder, Triangle Biotechnology

CrunchbaseLinkedIn

Paul Dayton's Career

Triangle Biotechnology
Triangle Biotechnology

Chapel Hill, NC, US

Co-Founder
SonoVol
SonoVol

Durham, NC, US

Founder
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill

Chapel Hill, NC, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Paul Dayton's Career

Triangle Biotechnology
Triangle Biotechnology
Angel$245.3k8Chapel Hill, NC, US
Co-Founder

Leadership at Triangle Biotechnology

Samantha PattendenSamantha PattendenCo-Founder
Joe McMahonJoe McMahonCo-Founder & CEO
SonoVol
SonoVol
Acquired$1.2M02012Durham, NC, US
Founder

Leadership at SonoVol

Ryan GessnerRyan GessnerCEO

Similar to SonoVol

VerasonicsVerasonicsKirkland, WA, USResearch Platforms, Ultrasound Systemsest. 2002VerasonicsKirkland, WA, US · est. 2002

Verasonics: Revolutionizing ultrasound through innovative research technology.

Series A · $6.3M49
SonoVascularSonoVascularChapel Hill, NC, USMedical Devicesest. 2018SonoVascularChapel Hill, NC, US · est. 2018

SonoVascular: Innovating thrombectomy systems for comprehensive arterial and venous disease treatment.

Seed · $2.2M9
iSono HealthiSono HealthSan Francisco, CA, USHealthTech, Medical Devicesest. 2016iSono HealthSan Francisco, CA, US · est. 2016

AI-powered, radiation-free breast health monitoring with fast, easy 3D ultrasound scans.

Pre-Seed · $4.6M9
Sonify BiosciencesSonify BiosciencesBaltimore, MD, USMedical Devicesest. 2012Sonify BiosciencesBaltimore, MD, US · est. 2012

Sonify Biosciences, a Maryland-based medical firm, pioneers in non-chemical ultrasound melanoma treatments.

Seed · $170k6
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill
Angel$47.6M14.4k1789Chapel Hill, NC, US
Board Member· Board

Recent news

UNC Chancellor Lee Roberts on pushing his university into the AI ageTechCrunch · 2025

Leadership at University of North Carolina at Chapel Hill

Kevin GuskiewiczKevin GuskiewiczBoard Member
Joe HartJoe HartBoard Member
JoAnn SciarrinoJoAnn SciarrinoBoard Member
Brian StrahlBrian StrahlBoard Member
Jean OrelienJean OrelienBoard Member
Doug RothwellDoug RothwellBoard Member

Similar to University of North Carolina at Chapel Hill

North Carolina State UniversityNorth Carolina State UniversityRaleigh, NC, USEducation, Researchest. 1887North Carolina State UniversityRaleigh, NC, US · est. 1887

NC State University: A leading public research institution in Raleigh, NC, part of the Research Triangle.

Public · $30.5M9.6k
University of VirginiaUniversity of VirginiaCharlottesville, VA, USEducationest. 1819University of VirginiaCharlottesville, VA, US · est. 1819

UVA: A renowned public research university in Charlottesville, VA, founded by Thomas Jefferson in 1819.

Public · $217.1M10.1k
The University of ChicagoThe University of ChicagoChicago, IL, USEducation, Researchest. 1890The University of ChicagoChicago, IL, US · est. 1890

UChicago: A premier private research university located in Chicago's Hyde Park.

Series A · $197.8M27.5k
Innovate CarolinaInnovate CarolinaChapel Hill, NC, USEntrepreneurshipest. 2015Innovate CarolinaChapel Hill, NC, US · est. 2015

Innovate Carolina, a UNC-Chapel Hill initiative, accelerates ideas to solve global issues and boost the economy.

25

Paul Dayton's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Paul Dayton

Donald T LysleDonald T LysleBoard Member · University of North Carolina at Chapel HillNicholas HastingsNicholas HastingsBoard Member · University of North Carolina at Chapel HillDawna J.Dawna J.Board Member · University of North Carolina at Chapel HillBetsy HoldenBetsy HoldenBoard Member · NNN Reit